SETDB1 and melanoma: In addition, IFN signaling and SETDB1/SETDB2 expression were enhanced upon exposure to chemotherapeutic agents or targeted therapies in melanoma, lung, and colon cancer cell lines, a phenomenon associated with therapy resistance.